ClinicalTrials.gg
RecruitingNCT07899879Updated Oct 28, 2026

Upper Extremity Exercise Capacity in Chronic Non-specific Neck Pain

An observational study in Neck Pain, sponsored by Karabuk University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by Karabuk University · Observational

From the registry’s dates

  • Started May 2026; still recruiting 5 months later.
Updated Oct 28, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
58
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Chronic non-specific neck pain can negatively affect individuals' upper extremity functions and activities of daily living by causing physical impairments such as pain, reduced muscle strength and endurance, restricted movement, and coordination deficits. The aim of this study is to compare the upper extremity functional exercise capacity, upper extremity functionality, peripheral muscle strength, and quality of life of individuals with chronic non-specific neck pain with those of healthy individuals.

Read the detailed description

Chronic non-specific neck pain can negatively affect individuals' upper extremity functions and activities of daily living by causing physical impairments such as pain, reduced muscle strength and endurance, restricted movement, and coordination deficits. The anatomical and functional relationship between the neck region and the shoulder girdle may also lead to the impairment of shoulder and hand functions in these individuals. Although the literature has examined joint range of motion, manual dexterity, muscle strength, and disability levels in individuals with chronic neck pain, there is limited information regarding how their upper extremity functional exercise capacity compares to that of healthy individuals. Furthermore, there is a need to evaluate the interrelationships between peripheral muscle strength, upper extremity functionality, and quality of life. Accordingly, the aim of this study is to compare the upper extremity functional exercise capacity, upper extremity functionality, peripheral muscle strength, and quality of life of individuals with chronic non-specific neck pain against those of healthy individuals, and to identify any functional differences that may arise in this population.

02

Conditions studied

  • Neck Pain

Browse trials for

03

In context

Neck Pain

1,269 studies on the registry are indexed under Neck Pain; 259 are open to participants now.

This study's planned enrollment of 58 is below the median of 92 across 220 observational studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

Karabuk University is the lead sponsor of 142 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients with chronic neck pain and healthy individuals

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

For the patient group:

  • Being between 18 and 65 years of age
  • Having a chronic non-specific neck pain (pain lasting longer than 3 months, located in the region between the occiput, the first thoracic vertebrae, and the acromion)
  • Being willing to participate in the study

For the healthy group:

  • Being between 18 and 65 years of age
  • Being willing to participate in the study

Exclusion criteria

Exclusion Criteria:

For both groups:

  • Presence of psychological disorders, mental health conditions, cancer, or severe depression
  • History of traumatic injury
  • History of primary or metastatic spinal malignancy, or spinal fracture
  • Presence of a neurological disorder (e.g., hemiplegia, multiple sclerosis, Parkinson's disease, etc.)
  • Diagnosis of advanced osteoporosis
  • History of surgical intervention in the cervical region or presence of an acute infection
  • History of surgery involving the upper extremity or an injury/disability within the last 6 months
  • Thoracic outlet syndrome
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
58 participants (estimated)
Patient registry
No

Groups and cohorts

  • Chronic neck pain

    Individuals with chronic non-specific neck pain will be included in the study.

  • Control Group

    Healthy and voluntary participants will be included in the study.

06

What researchers measure

Primary outcomes

  1. Upper extremity functional exercise capasity

    Upper extremity exercise capacity will be evaluated with the six-minute pegboard and ring test (6-PBRT). In the test, as the number of rings increases, exercise capacity also increases.

    Time frame: Baseline

  2. Pain severity

    Pain intensity will be assessed with the Visual Analog Scale. It is scored between 0-10 and the higher the score, the greater the pain intensity.

    Time frame: Baseline

  3. Pain threshold

    Pain threshold will be assessed with an algometer. An increase in the applied pressure indicates a higher pain threshold.

    Time frame: Baseline

  4. Functional levels

    Functional status related to the upper extremity will be assessed using the QuickDASH. QuickDASH scores range from 0 to 100, where 0 indicates no disability and 100 indicates the most severe disability.

    Time frame: Baseline

  5. Muscle strength

    Shoulder abductors and hand grip strength will be assessed using a hand dynamometer.

    Time frame: Baseline

  6. Life quality

    The SF-36 will be used to measure changes in quality of life levels associated with chronic neck pain. Scores on the scale range from a minimum of 0 to a maximum of 100; higher scores indicate a better quality of life.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07899879
Lead sponsor
Karabuk University
Responsible party
Musa Güneş (Principal Investigator, PhD, Karabuk University) — Principal investigator
First posted
Oct 28, 2026
Start date
May 30, 2026
Primary completion
Dec 20, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Oct 28, 2026

Study contacts

Musa Güneş, PhD
Contact
musagunes@karabuk.edu.tr
03704789081
Musa Güneş, PhD
study chair · Karabuk University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion